Coronavirus LIVE Updates: US FDA Gives Nod to Booster Dose of Pfzier-BioNTech Covid-19 Vaccine for 65 Plus, High-Risk Adults

Coronavirus LIVE Updates: US FDA Gives Nod to Booster Dose of Pfzier-BioNTech Covid-19 Vaccine for 65 Plus, High-Risk Adults

Coronavirus Updates: The Pfizer booster shots will be administered to those aged 65 and adults at high risk, they will be inoculated at least six months after completion of the primary series.

Source: Top India News- News18.com